QUOTE AND NEWS
GenEng News  Feb 27  Comment 
Novartis has been ordered by Japanese health officials to suspend its operations in the country for 15 days, as punishment for failing to report the side effects of more than two dozen of its drugs. Japan’s Ministry of Health, Labor and...
FiercePharma  Feb 27  Comment 
Pfizer and Novartis have snagged a nod from the CDC's Advisory Committee on Immunization Practices (ACIP) for their recently approved meningitis B vaccines. There's just one problem: It doesn't cover nearly as large a population as the pharma...
FierceBiotech  Feb 27  Comment 
Novartis, at work on a cardio drug widely expected to bring in billions of dollars once approved, is working to tamp down concerns that the oral treatment could increase the risk of Alzheimer's disease, adding measures of brain function to an...
GenEng News  Feb 27  Comment 
Assembling a comprehensive map of all the connections between neurons of the brain is the task employed by neuroscientists currently working on the human connectome. The data from this effort should provide a blueprint that will allow scientists...
Wall Street Journal  Feb 27  Comment 
Health authorities ordered the Japanese unit of Novartis to shut down most operations for 15 days in March, saying the drug maker failed to report side effects from its products in a timely fashion.
Benzinga  Feb 27  Comment 
Novartis shareholders approve all resolutions proposed by Novartis Board of Directors . Processed and transmitted by NASDAQ OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement. Shareholders approve...
Benzinga  Feb 25  Comment 
In a report published Wednesday, Deutsche Bank analyst Robyn Karnauskas downgraded Pharmacyclics Inc. (NASDAQ: PCYC) to Hold, while raising the price target from $205 to $235. The downgrade followed a Bloomberg report mentioning that Johnson &...
Reuters  Feb 25  Comment 
Cancer drug maker Pharmacyclics Inc is exploring a sale and has attracted interest from Johnson & Johnson and Novartis AG, Bloomberg reported.
Clusterstock  Feb 25  Comment 
LONDON (Reuters) - GlaxoSmithKline said on Wednesday it expected to conclude a $20 billion-plus three-part asset swap with Novartis in the week commencing March 2, following progress in obtaining clearances for the deal. GSK is forming a...
Forbes  Feb 24  Comment 
The cardiovascular safety of nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and diclofenac has been the subject of considerable uncertainty and controversy. Now a new study published in JAMA raises specific concerns about the...




 

Fuerralz? That's marvelously good to know.

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki